Videos

“We were able to show that there was a very…clinically significant decrease in the rate of UTIs in the vaccinated group, preventing UTIs in almost 60% of vaccinated patients,” says J. Curtis Nickel, MD.

Dr. Nickel discusses promising outcomes with vaccine for recurrent UTIs

Articles

In a recent study presented at the 2021 AUA Annual Meeting, Naeem Bhojani, MD, FRCSC, David-Dan Nguyen, and co-authors reported the favorable 3-year results of ongoing Aquablation research specifically involving patients with large prostates.

Aquablation demonstrates success in large prostates

“Figuring out a good, comfortable way to bring that [ED] conversation up…will really pay dividends in other parts of the health care system. It will also allow more people to appropriately get funneled to urology to better address it,” says Denise Asafu-Adjei, MD, MPH.

Dr. Asafu-Adjei on the importance of asking patients about their history with ED

“[BPH treatment] has to be individualized to the motivations of the patient, and also what I call his "phenotype.” How big is his prostate? How bad is this problem? And what is his tolerance for side effects?” says Kevin T. McVary, MD.

Dr. McVary discusses individualizing care in men with BPH

In a recent study, presented at the 2021 AUA Annual Meeting, Peter Chin, MD, and co-authors assessed the efficacy of the investigational Zenflow Spring System in treating patients with BPH.

Zenflow Spring System shows promising results in early trials for patients with BPH

"These data are growing rapidly, and awareness of where we stand right now and the potential that could change as well in the future with new data is important for the practicing urologist,” says Peter N. Schlegel, MD, FACS.

Updated male infertility clinical guideline presented at AUA 2021

“More research needs to be done, but I think this is something that gets the conversation started,” says Tony Chen, MD.

Patients with ED exhibit varying treatment patterns across races

An aggressive treatment, such as bladder removal, may be necessary in patients with early stage micropapillary bladder cancer because the disease may behave more like late-stage conventional urothelial carcinoma.

Study results underscore alarming aggressiveness of early stage micropapillary bladder cancer

"This particular study comes from our human randomized trial that we hope will be the final step before FDA approval for the technology,” says Mathew D. Sorensen, MD, MS, FACS.

Dr. Sorensen investigates ultrasound treatment in patients with kidney stones

In this interview, Kevin Zorn, MD, discusses 3-year results from a study of robot-assisted Aquablation procedures in treating men with large prostates.